Stock SYAB SYNLAB AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials SYNLAB AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

Real-time Estimate Tradegate
Other stock markets
 04:21:45 2024-05-29 EDT 		5-day change 1st Jan Change
10.65 EUR +0.47% Intraday chart for SYNLAB AG +2.12% -7.01%
05-08 Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024
05-08 Laboratory chain Synlab starts the year with lower revenue DP

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,244 2,510 2,509 2,330 - -
Enterprise Value (EV) 1 6,847 4,085 2,509 3,800 3,968 3,868
P/E ratio 8.39 x 16.6 x 27.2 x 28.6 x 35.3 x 35.3 x
Yield 1.4% 2.91% - 1.93% 1.93% 2.26%
Capitalization / Revenue 1.39 x 0.77 x 0.95 x 0.81 x 0.77 x 0.74 x
EV / Revenue 1.82 x 1.26 x 0.95 x 1.33 x 1.31 x 1.24 x
EV / EBITDA 5.66 x 5.43 x 5.73 x 6.87 x 6.59 x 6.14 x
EV / FCF 7.89 x 8.67 x - 22.4 x -23.6 x 26.8 x
FCF Yield 12.7% 11.5% - 4.46% -4.23% 3.74%
Price to Book 2.32 x 1.07 x - 0.95 x 0.91 x 0.87 x
Nbr of stocks (in thousands) 222,222 221,562 219,707 219,775 - -
Reference price 2 23.60 11.33 11.42 10.60 10.60 10.60
Announcement Date 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 3,765 3,251 2,635 2,862 3,024 3,130
EBITDA 1 - 1,210 753 437.9 553 602.5 630
EBIT 1 - 996.1 508 194.2 257 288.5 299
Operating Margin - 26.46% 15.63% 7.37% 8.98% 9.54% 9.55%
Earnings before Tax (EBT) 1 - 805.6 283 143 273 329 -82
Net income 1 257.6 624.8 151 92.27 81 67 67
Net margin - 16.6% 4.64% 3.5% 2.83% 2.22% 2.14%
EPS 2 - 2.811 0.6815 0.4200 0.3700 0.3000 0.3000
Free Cash Flow 1 - 867.2 471.4 - 169.4 -167.8 144.6
FCF margin - 23.03% 14.5% - 5.92% -5.55% 4.62%
FCF Conversion (EBITDA) - 71.68% 62.6% - 30.63% - 22.95%
FCF Conversion (Net income) - 138.8% 312.15% - 209.14% - 215.82%
Dividend per Share 2 - 0.3300 0.3300 - 0.2050 0.2050 0.2400
Announcement Date 21-04-20 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2023 Q1 2023 Q2
Net sales 1 992.6 1,061 790.4 1,851 697.9 702.4 669.7
EBITDA 1 - 356.9 171.1 528 135 118.5 113.5
EBIT - 300.1 110.7 410.8 75.8 60.5 -
Operating Margin - 28.28% 14% 22.19% 10.86% 8.61% -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 22-03-16 22-05-12 22-08-11 22-08-11 22-11-10 23-05-12 23-08-09
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 1,602 1,575 - 1,471 1,639 1,539
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 1.324 x 2.092 x - 2.659 x 2.72 x 2.442 x
Free Cash Flow 1 - 867 471 - 169 -168 145
ROE (net income / shareholders' equity) - 39% 14.9% - 3.4% 2.8% 2.7%
ROA (Net income/ Total Assets) - 12.6% 6.33% - - - -
Assets 1 - 4,949 2,386 - - - -
Book Value Per Share 2 - 10.20 10.60 - 11.20 11.70 12.20
Cash Flow per Share 2 - 4.700 2.840 - 1.560 1.640 1.790
Capex 1 - 144 158 - 240 240 244
Capex / Sales - 3.84% 4.87% - 8.38% 7.94% 7.8%
Announcement Date 21-04-20 22-03-16 23-03-16 24-03-25 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SYNLAB AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.6 EUR
Average target price
14.5 EUR
Spread / Average Target
+36.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SYNLAB AG Stock SYNLAB AG
-7.01% 2.53B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-24.88% 7.74B
RADNET, INC. Stock RadNet, Inc.
+70.87% 4.39B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+2.88% 2.61B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-44.62% 2.22B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.67% 1.8B
FLEURY S.A. Stock Fleury S.A.
-19.62% 1.54B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+18.85% 1.23B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-43.60% 1.15B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+20.05% 977M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. SYAB Stock
  4. Financials SYNLAB AG